Fiber fix? study tests if a simple supplement boosts arthritis Drug's power
NCT ID NCT05812157
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether adding a daily fiber supplement (inulin) to standard anti-IL-17 therapy could improve gut bacteria balance and treatment response in 76 adults with axial spondyloarthritis. Participants took either fiber or a placebo powder for three months. The main goal was to see if fiber increased beneficial gut bacteria. If successful, this simple addition might help patients get more out of their medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
inulin (Fibruline) fiber supplement
What this could lead to
If it works, this could point toward a simple dietary addition that helps people with axial spondyloarthritis respond better to their anti-IL-17 medication.
What could go wrong
This is a small, early-stage study focused on gut bacteria changes, not direct symptom improvement. The fiber supplement may not meaningfully affect disease activity or treatment outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AXIAL SPONDYLOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montpellier University Hospital
Montpellier, Hérault, 34000, France
-
Nîmes University Hospital
Nîmes, Gard, 30029, France
-
Tours Regional University Hospital (Bretonneau)
Tours, Indre-et-Loire, 37032, France